Market Research Report
Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||563469|
|Published||Content info||74 Pages
Delivery time: 1-2 business days
|Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021|
|Published: October 4, 2017||Content info: 74 Pages||
Cancer is diagnosed by blood count, bone marrow biopsy, and molecular identification of mutated cells. CTC diagnostics helps in the identification of deoxyribonucleic acid (DNA) shed by tumor cells. CTCs are cancerous cells which detach from primary tumor and migrate in the bloodstream or lymphatic system of the patient. CTCs in the blood or lymphatic system helps in providing important information regarding prognosis and treatment effectiveness for cancer patients.
Technavio's analysts forecast the global circulating tumor cell (CTC) diagnostics market to grow at a CAGR of 9.39% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global circulating tumor cell (CTC) diagnostics market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio's report, Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.